| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 8.762 | 30.059 | 47.932 | 57.226 | 54.104 |
| Total Income - EUR | - | - | - | - | - | 9.777 | 32.933 | 65.978 | 86.777 | 59.134 |
| Total Expenses - EUR | - | - | - | - | - | 11.251 | 30.877 | 64.190 | 85.985 | 57.958 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.474 | 2.056 | 1.788 | 792 | 1.176 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.498 | 2.056 | 1.288 | 220 | 585 |
| Employees | - | - | - | - | - | 1 | 4 | 5 | 5 | 4 |
Check the financial reports for the company - Biotech Velordome S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 3.802 | 3.898 | 13.927 | 4.971 | 10.279 |
| Inventories | - | - | - | - | - | 2.018 | 3.483 | 10.454 | 3.181 | 5.823 |
| Receivables | - | - | - | - | - | 930 | 0 | 1.369 | 642 | 0 |
| Cash | - | - | - | - | - | 854 | 415 | 2.104 | 1.148 | 4.456 |
| Shareholders Funds | - | - | - | - | - | -1.457 | 632 | 1.922 | 2.135 | 2.709 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 5.260 | 3.266 | 12.006 | 5.666 | 8.576 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4779 - 4779" | |||||||||
| CAEN Financial Year |
4799
|
|||||||||
Comments - Biotech Velordome S.r.l.